Gene · 1909
Papers4,314
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
581 to 600 of 4,314
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Recent Advances in the Treatment of Pulmonary Arterial Hypertension. | Pharmaceuticals (Basel) | 2022 | 36297387 | PubTator, text mining | PubMed |
The Potential Protective Effect and Underlying Mechanisms of Physiological Unconjugated Hyperbilirubinemia Mediated by UGT1A1 Antisense Oligonucleotide Therapy in a Mouse Model of Cyclosporine A-Induced Chronic Kidney Disease. | Metabolites | 2022 | 36295901 | PubTator, text mining | PubMed |
| Coagulation Profile of COVID-19 Patients. | Life (Basel) | 2022 | 36295093 | PubTator, text mining | PubMed |
| Whole Exome Sequencing and In Silico Analysis of Human Sertoli in Patients with Non-Obstructive Azoospermia. | Int J Mol Sci | 2022 | 36293429 | PubTator, text mining | PubMed |
| Chronic Nodular Prurigo: An Update on the Pathogenesis and Treatment. | Int J Mol Sci | 2022 | 36293248 | PubTator, text mining | PubMed |
| Significance of Indoleamine 2,3-Dioxygenase Expression in the Immunological Response of Kidney Graft Recipients. | Diagnostics (Basel) | 2022 | 36292041 | PubTator, text mining | PubMed |
| NOX as a Therapeutic Target in Liver Disease. | Antioxidants (Basel) | 2022 | 36290761 | PubTator, text mining | PubMed |
| MFDA: Multiview fusion based on dual-level attention for drug interaction prediction. | Front Pharmacol | 2022 | 36278200 | PubTator, text mining | PubMed |
| The Construction and Analysis of a ceRNA Network Related to Salt-Sensitivity Hypertensives. | Biomed Res Int | 2022 | 36277897 | PubTator, text mining | PubMed |
| Store-operated calcium channels in skin. | Front Physiol | 2022 | 36277201 | PubTator, text mining | PubMed |
| Emerging role of transient receptor potential (TRP) ion channels in cardiac fibroblast pathophysiology. | Front Physiol | 2022 | 36277180 | PubTator, text mining | PubMed |
| IoT Speech Recognition Application in Mass Sports Data Monitoring Based on Dynamic Adaptive Recommendation Algorithm. | Comput Intell Neurosci | 2022 | 36275970 | PubTator, text mining | PubMed |
| Retinoblastoma protein as an intrinsic BRD4 inhibitor modulates small molecule BET inhibitor sensitivity in cancer. | Nat Commun | 2022 | 36274096 | PubTator, text mining | PubMed |
| Discovery and Structure-Activity Relationship Studies of Novel Adenosine A1 Receptor-Selective Agonists. | J Med Chem | 2022 | 36270633 | PubTator, text mining | PubMed |
| Exploring the mechanism of Shexiang Tongxin dropping pill in the treatment of microvascular angina through network pharmacology and molecular docking. | Ann Transl Med | 2022 | 36267750 | PubTator, text mining | PubMed |
| Network pharmacology study on the potential effect mechanism of Chuanzhi Tongluo Capsule in the treatment of cerebral infarction. | Medicine (Baltimore) | 2022 | 36254030 | PubTator, text mining | PubMed |
| Inhibitor of differentiation 1 in U87MG glioblastoma cells promotes HUVEC sprouting through endothelin-1. | Oncol Lett | 2022 | 36245828 | PubTator, text mining | PubMed |
| Synergistic action of organophosphates and COVID-19 on inflammation, oxidative stress, and renin-angiotensin system can amplify the risk of cardiovascular maladies. | Toxicol Appl Pharmacol | 2022 | 36240863 | PubTator, text mining | PubMed |
| Dysregulated autoantibodies targeting vaso- and immunoregulatory receptors in Post COVID Syndrome correlate with symptom severity. | Front Immunol | 2022 | 36238301 | PubTator, text mining | PubMed |
| The Enteric Glia and Its Modulation by the Endocannabinoid System, a New Target for Cannabinoid-Based Nutraceuticals? | Molecules | 2022 | 36235308 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1909/papers?page=30